Consolidated Statements of Convertible Preferred Stock and Stockholders' Equity (Deficit) - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-In Capital	Accumulated other comprehensive loss	Accumulated Deficit
Beginning balance at Dec. 31, 2021	$ 211,539	$ 41	$ 514,362	$ (397)	$ (302,467)
Beginning balance, Shares at Dec. 31, 2021		40,626,224
Issuance of common stock, net of issuance costs	80,804	$ 11	80,793
Issuance of common stock, Shares		11,029,410
Issuance of common stock under employee benefit plans	3,519		3,519
Issuance of common stock under employee benefit plans, Shares		433,403
Vesting of restricted stock awards	1		1
Vesting of restricted stock awards, Shares		10,174
Stock-based compensation expense	13,350		13,350
Unrealized loss on marketable securities	(400)			(400)
Net loss	(109,871)				(109,871)
Ending balance at Dec. 31, 2022	198,942	$ 52	612,025	(797)	(412,338)
Ending balance, Shares at Dec. 31, 2022		52,099,211
Issuance of common stock, net of issuance costs	117,346	$ 10	117,336
Issuance of common stock, Shares		9,615,384
Issuance of common stock under employee benefit plans	777	$ 0	777
Issuance of common stock under employee benefit plans, Shares		182,628
Vesting of restricted stock awards	0		0
Vesting of restricted stock awards, Shares		18,144
Stock-based compensation expense	14,802		14,802
Unrealized loss on marketable securities	661			661
Net loss	(97,335)				(97,335)
Ending balance at Dec. 31, 2023	$ 235,193	$ 62	$ 744,940	$ (136)	$ (509,673)
Ending balance, Shares at Dec. 31, 2023		61,915,367